Immunohistochemistry of the cytoskeleton of human prostatic epithelium. Evidence for disturbed organization in neoplasia
- PMID: 2435158
- PMCID: PMC1899576
Immunohistochemistry of the cytoskeleton of human prostatic epithelium. Evidence for disturbed organization in neoplasia
Abstract
An indirect immunoperoxidase technique was used to evaluate keratin, actin, tubulin, and calmodulin immunoreactivity in histologic sections of normal, hyperplastic, and neoplastic human prostate. Polyclonal as well as monoclonal keratin antibodies produced equivalent and intense staining of normal epithelium. The immunoreactivity of normal prostate with keratin antibodies was more pronounced than with antibodies to the other components of the cytoskeleton. Variation in staining for components of the cytoskeleton was minimal. The same findings applied to hyperplastic prostate. The immunoreactivity of prostate tumors with antibodies to these cytoskeletal proteins differed markedly from normal prostate. Prostatic carcinomas showed reduced keratin immunoreactivity with a panepithelial antibody, but unaltered or enhanced immunoreactivity with tubulin, actin, and calmodulin antibodies. Many tumors were unreactive with a monoclonal keratin antibody that was strongly reactive with tissues that contained cytokeratin 18 (45-kd) and which intensely stained normal and hyperplastic prostate. In addition, prostate carcinomas often yielded heterogeneous patterns of staining with actin, tubulin, and calmodulin antibodies in contrast to normal and hyperplastic prostate, which showed uniform staining. The results suggest that a disturbance in the organization of the cytoskeleton may accompany neoplastic transformation of human prostate.
Similar articles
-
Keratin immunoreactivity in the benign and neoplastic human prostate.Cancer Res. 1985 Aug;45(8):3663-7. Cancer Res. 1985. PMID: 2410099
-
Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.Cancer Res. 1984 Jan;44(1):285-92. Cancer Res. 1984. PMID: 6197163
-
Keratin immunoreactivity in fine-needle aspiration of the prostate: an aid in the differentiation of benign epithelium from well-differentiated adenocarcinoma.Diagn Cytopathol. 1988 Mar;4(1):38-41. doi: 10.1002/dc.2840040110. Diagn Cytopathol. 1988. PMID: 2454179
-
Cytoskeletal and cytocontractile protein composition of stromal tissue in normal, hyperplastic, and neoplastic human prostate. An immunocytochemical study with monoclonal antibodies.Ann N Y Acad Sci. 1996 Apr 30;784:496-508. doi: 10.1111/j.1749-6632.1996.tb16270.x. Ann N Y Acad Sci. 1996. PMID: 8651605
-
Histochemical studies of epithelial cell glycoconjugates in atrophic, metaplastic, hyperplastic, and neoplastic canine prostate.Lab Invest. 1984 Mar;50(3):294-302. Lab Invest. 1984. PMID: 6199584 Review.
Cited by
-
Differential expression of cytokeratin mRNA and protein in normal prostate, prostatic intraepithelial neoplasia, and invasive carcinoma.Am J Pathol. 1997 Feb;150(2):693-704. Am J Pathol. 1997. PMID: 9033282 Free PMC article.
-
Proliferative lesions of prostate: a multivariate approach to differential diagnosis.Pathol Oncol Res. 2005;11(2):103-7. doi: 10.1007/BF02893376. Epub 2005 Jul 1. Pathol Oncol Res. 2005. PMID: 15999155
-
Basal epithelial cells of human prostate gland are not myoepithelial cells. A comparative immunohistochemical and ultrastructural study with the human salivary gland.Am J Pathol. 1990 Apr;136(4):957-66. Am J Pathol. 1990. PMID: 1691595 Free PMC article.
-
Basal cells of H-Dunning tumor are myoepithelial cells. A comparative immunohistochemical and ultrastructural study with male accessory sex glands and mammary gland.Histochemistry. 1991;95(4):341-9. doi: 10.1007/BF00266961. Histochemistry. 1991. PMID: 2022486
-
Vimentin and cytokeratin expression in nodular hyperplasia and carcinoma of the prostate.J Clin Pathol. 1995 Nov;48(11):1031-4. doi: 10.1136/jcp.48.11.1031. J Clin Pathol. 1995. PMID: 8543626 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical